Maria Antonietta Rizzuto

Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells

Michela Bellini, Serena Mazzucchelli, Elisabetta Galbiati et al. · Journal of Controlled Release · 2014 · 128 citations

Pharmacy, Molecular Pharmaceutics, Oncology +17

H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells

Laura Pandolfi, Michela Bellini, Renzo Vanna et al. · Biomacromolecules · 2017 · 90 citations · Full text

Pharmacy, Oncology, Pharmacology +17

H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer

Serena Mazzucchelli, Marta Truffi, F. Baccarini et al. · Scientific Reports · 2017 · 67 citations · Full text

Medicine, Oncology, Pharmacology +16

Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity

Serena Mazzucchelli, Michela Bellini, Luisa Fiandra et al. · Oncotarget · 2016 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax

Leopoldo Sitia, Arianna Bonizzi, Serena Mazzucchelli et al. · Cells · 2021 · 55 citations · Full text

Pharmacy, Cancer Biology, Oncology +17